DIN 02256754 — TIAZAC XC 240 MG
TIAZAC XC is a tablet (extended-release) of Diltiazem marketed by BAUSCH HEALTH, CANADA INC.. The full Diltiazem monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02256754
- Brand name
- TIAZAC XC
- Active ingredient
- Diltiazem
- Strength
- 240 MG
- Dosage form
- TABLET (EXTENDED-RELEASE)
- Route
- ORAL
- Manufacturer
- BAUSCH HEALTH, CANADA INC.
- Health Canada status
- MARKETED
- Drug class
- Non-dihydropyridine calcium channel blocker
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Diltiazem products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 00771376 | AA-DILTIAZ | 30 MG | TABLET | AA PHARMA INC | MARKETED |
| 00771384 | AA-DILTIAZ | 60 MG | TABLET | AA PHARMA INC | MARKETED |
| 00862924 | TEVA-DILTIAZEM | 30 MG | TABLET | TEVA CANADA LIMITED | DORMANT |
| 00862932 | TEVA-DILTIAZEM | 60 MG | TABLET | TEVA CANADA LIMITED | DORMANT |
| 02429322 | TEVA-DILTIAZEM XC | 180 MG | TABLET (EXTENDED-RELEASE) | TEVA CANADA LIMITED | MARKETED |
| 02429330 | TEVA-DILTIAZEM XC | 240 MG | TABLET (EXTENDED-RELEASE) | TEVA CANADA LIMITED | MARKETED |
| 02429349 | TEVA-DILTIAZEM XC | 300 MG | TABLET (EXTENDED-RELEASE) | TEVA CANADA LIMITED | MARKETED |
| 02429357 | TEVA-DILTIAZEM XC | 360 MG | TABLET (EXTENDED-RELEASE) | TEVA CANADA LIMITED | MARKETED |
| 02256738 | TIAZAC XC | 120 MG | TABLET (EXTENDED-RELEASE) | BAUSCH HEALTH, CANADA INC. | MARKETED |
| 02256746 | TIAZAC XC | 180 MG | TABLET (EXTENDED-RELEASE) | BAUSCH HEALTH, CANADA INC. | MARKETED |
| 02256762 | TIAZAC XC | 300 MG | TABLET (EXTENDED-RELEASE) | BAUSCH HEALTH, CANADA INC. | MARKETED |
| 02256770 | TIAZAC XC | 360 MG | TABLET (EXTENDED-RELEASE) | BAUSCH HEALTH, CANADA INC. | MARKETED |